0001209191-21-013484.txt : 20210223
0001209191-21-013484.hdr.sgml : 20210223
20210223194343
ACCESSION NUMBER: 0001209191-21-013484
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210219
FILED AS OF DATE: 20210223
DATE AS OF CHANGE: 20210223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leen Ann M.
CENTRAL INDEX KEY: 0001763026
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39409
FILM NUMBER: 21667873
MAIL ADDRESS:
STREET 1: 5 WEST FORSYTH STREET
STREET 2: SUITE 200
CITY: JACKSONVILLE
STATE: FL
ZIP: 32202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allovir, Inc.
CENTRAL INDEX KEY: 0001754068
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 831971007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 139 MAIN STREET, SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 433-2605
MAIL ADDRESS:
STREET 1: 139 MAIN STREET, SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ViraCyte, Inc.
DATE OF NAME CHANGE: 20180924
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-19
0
0001754068
Allovir, Inc.
ALVR
0001763026
Leen Ann M.
C/O ALLOVIR, INC.
139 MAIN STREET, SUITE 500
CAMBRIDGE
MA
02142
0
1
0
0
Chief Scientific Officer
Common Stock
2021-02-19
4
S
0
7541
41.7541
D
2481590
I
See Footnote
Common Stock
2021-02-22
4
S
0
1200
41.5384
D
2480390
I
See Footnote
Common Stock
2021-02-22
4
S
0
4506
42.8394
D
2475884
I
See Footnote
Common Stock
2021-02-23
4
S
0
1492
38.8279
D
2474392
I
See Footnote
Common Stock
2021-02-23
4
S
0
1907
39.5898
D
2472485
I
See Footnote
Common Stock
2021-02-23
4
S
0
800
40.5594
D
2471685
I
See Footnote
Common Stock
28000
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.41 to $42.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.28 to $41.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.38 to $43.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.11 to $39.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.12 to $40.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.21 to $41.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
/s/ Brett Hagen, as Attorney-in-Fact
2021-02-23